- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07613619
Multilevel Exercise Response in Rowers
Multilevel Assessment of Physiological, Molecular, Metabolic, Intestinal, and Psychophysiological Responses to Rowing Ergometer Exercise in Competitive Rowers
This observational study aims to evaluate multilevel physiological, molecular, metabolic, intestinal, immunological, and psychophysiological responses to rowing-specific exercise in elite rowers. The study is designed to investigate how maximal and prolonged rowing ergometer exercise influences integrated adaptive mechanisms related to mitochondrial function, metabolic regulation, intestinal permeability, immune activation, DNA damage response, and psychological status.
Thirty members of the Polish Youth National Rowing Team, aged 19-24 years, will participate in the study during two different training periods. During the competitive phase, participants will perform a 2000-m maximal rowing ergometer test, whereas during the preparatory phase they will complete a 6000-m rowing ergometer test. Blood samples and physiological measurements will be collected before exercise, immediately after exercise, and after 1 hour of recovery.
The study will assess gene expression, circulating biomarkers, flow cytometry parameters, blood morphology, lactate concentration, continuous glucose monitoring data, wearable metabolic sensor measurements, nutritional status, and psychological responses. The primary objective is to identify integrated biomarkers reflecting exercise load, recovery dynamics, and adaptive capacity in highly trained athletes. The study also aims to improve understanding of the interaction between metabolic, mitochondrial, intestinal, immunological, and psychophysiological responses to intensive exercise in rowing.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study is designed to investigate integrated physiological, molecular, metabolic, intestinal, immunological, and psychophysiological responses to rowing-specific exercise in elite athletes. The study focuses on identifying biomarkers associated with exercise load, early recovery, and adaptive capacity in competitive rowers exposed to maximal and prolonged ergometer exercise.
Modern exercise physiology indicates that the response to intensive physical effort involves coordinated interactions between metabolic, mitochondrial, immune, neuroendocrine, and intestinal regulatory systems. High-intensity rowing exercise induces substantial metabolic stress, activation of mitochondrial signaling pathways, inflammatory and stress-related responses, and transient disturbances in intestinal barrier integrity. In addition, psychological factors, including mood state and pre-competition anxiety, may modulate physiological responses to exercise and recovery processes. However, previous studies have typically evaluated isolated physiological or biochemical markers without integrating molecular, cellular, and psychophysiological responses within a rowing-specific exercise model.
The study will include 30 competitive rowers, members of the Polish Youth National Rowing Team, aged 19 to 24 years, of both sexes. Assessments will be performed during two distinct phases of the annual training cycle. During the competitive phase (May-June 2026), participants will complete a 2000-m maximal rowing ergometer test. During the preparatory phase (November 2026), participants will perform a 6000-m rowing ergometer test. Both exercise protocols are routinely used within elite rowing training and performance monitoring.
Blood samples and physiological measurements will be collected at three time points during each testing session: before exercise (baseline), immediately after exercise, and after 1 hour of recovery. Venous blood samples will be used for hematological, biochemical, molecular, and flow cytometric analyses. Capillary blood samples will be collected for lactate assessment.
The study includes several integrated research modules:
The metabolic and adaptive response module will evaluate exercise-induced mitochondrial and metabolic signaling through analysis of gene expression related to mitochondrial biogenesis and energy regulation, including PPARGC1A, TFAM, PRKAA1, and SOD2. Circulating biomarkers associated with metabolic stress and adaptive signaling, including GDF15, apelin, irisin, myonectin, HSP70, and BDNF, will also be assessed. Psychological questionnaires evaluating mood state, perceived recovery, and competitive anxiety will be administered to characterize psychophysiological status.
The muscle-liver axis module will assess hormonal and metabolic regulation associated with glucose homeostasis and exercise adaptation. Measurements will include insulin, glucagon, FGF21, fetuin-A, IL-6, and myoglobin concentrations, together with expression of genes related to IL-6 signaling, gluconeogenesis, and glucose transport, including STAT3, SOCS3, PCK1, and SLC2A4 (GLUT4). Continuous glucose monitoring (CGM) and wearable metabolic monitoring systems will be used to evaluate glucose dynamics, lactate responses, hydration status, heart rate, and sodium loss during exercise and recovery.
The intestinal permeability and exercise-induced endotoxemia module will investigate exercise-associated disruption of intestinal barrier integrity and activation of innate immune responses. The study will assess circulating markers of endotoxemia and immune activation, including lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP), soluble CD14, soluble TLR2, and soluble TLR4. Flow cytometry will be used to characterize monocyte phenotypes and receptor expression (CD45, CD14, CD16, TLR2, TLR4), while RT-qPCR analyses will evaluate expression of TLR2 and TLR4 genes.
The DNA damage response module will evaluate transient exercise-induced DNA damage and activation of cellular repair mechanisms. Biomarkers of oxidative DNA damage and DNA repair signaling, including 8-OHdG/8-oxo-dG, nucleosomes, HMGB1, AP sites, APE1/APEX1, and poly(ADP-ribose), will be analyzed together with expression of genes involved in DNA damage response and repair pathways, including CDKN1A, GADD45A, APEX1, and PARP1.
Body composition analysis will be performed using the TANITA MC-780MA analyzer. Nutritional intake will be evaluated using dietary assessment questionnaires and food records to support interpretation of metabolic and physiological responses.
All laboratory analyses will be performed according to standardized laboratory procedures and quality-control protocols. Blood morphology analyses will be conducted immediately after collection, while serum and plasma samples will be processed, centrifuged, and stored at -80°C until analysis. Molecular and flow cytometry analyses will be performed in specialized laboratory facilities using validated methods and equipment.
The study is observational in nature and does not involve therapeutic intervention, pharmacological treatment, or experimental supplementation. All exercise procedures represent standard performance tests routinely used in elite rowing training. The project aims to improve understanding of integrated exercise physiology in high-performance athletes and to support development of personalized monitoring strategies for training optimization, recovery management, and early detection of excessive physiological strain.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Joanna Ostapiuk-Karolczuk, PhD
- Numero di telefono: +48573337282
- Email: j.ostapiuk@awf-gorzow.edu.pl
Backup dei contatti dello studio
- Nome: Anna Kasperska, PhD
- Numero di telefono: +48573337282
- Email: annakasperska.awf@gmail.com
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Male and female members of the Polish Youth National Rowing Team.
- Age between 19 and 24 years.
- Regular participation in structured rowing training.
- Medical clearance for participation in maximal exercise testing.
- Ability and willingness to provide written informed consent.
Exclusion Criteria:
- Lack of consent for blood sampling or study participation.
- Current injury or health condition contraindicating maximal exercise.
- Acute infection, fever, or inflammatory condition at the time of testing.
- Use of anti-inflammatory medications.
- Use of performance-enhancing substances.
- Use of dietary supplements within 3 months before study participation.
- Any medical contraindications identified by the study physician.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Elite male rowers
Male elite rowers aged 19-24 years performing standardized 2000-m and 6000-m rowing ergometer tests during two training phases.
Exercise-related biological and psychophysiological responses will be assessed before exercise, immediately after exercise, and after 1 hour of recovery.
|
A standardized maximal rowing ergometer exercise test performed over a distance of 2000 meters during the competitive phase of the training season to evaluate acute physiological and molecular responses to high-intensity exercise.
A standardized prolonged rowing ergometer exercise test performed over a distance of 6000 meters during the preparatory phase of the training season to evaluate physiological and molecular responses to prolonged submaximal exercise.
|
|
Elite female rowers
Female elite rowers aged 19-24 years performing standardized 2000-m and 6000-m rowing ergometer tests during two training phases.
Exercise-related biological and psychophysiological responses will be assessed before exercise, immediately after exercise, and after 1 hour of recovery.
|
A standardized maximal rowing ergometer exercise test performed over a distance of 2000 meters during the competitive phase of the training season to evaluate acute physiological and molecular responses to high-intensity exercise.
A standardized prolonged rowing ergometer exercise test performed over a distance of 6000 meters during the preparatory phase of the training season to evaluate physiological and molecular responses to prolonged submaximal exercise.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes from baseline in PPARGC1A (PGC-1α) gene expression
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of mitochondrial biogenesis and metabolic adaptation to exercise.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Changes from baseline in TFAM gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of mitochondrial DNA maintenance and transcription.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Changes from baseline in PRKAA1 (AMPKα1) gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of cellular energy sensing and metabolic stress response
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Changes from baseline in SOD2 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of mitochondrial antioxidant defense.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum growth differentiation factor 15 (GDF15) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of mitochondrial and metabolic stress
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum apelin concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Exercise-related myokine associated with metabolic regulation.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum heat shock protein 70 (HSP70) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of cellular stress response
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum brain-derived neurotrophic factor (BDNF) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of neuroplasticity and exercise-related neuroregulation.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum myonectin (CTRP15) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of lipid metabolism and energy homeostasis.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum insulin concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of glucose regulation and metabolic adaptation.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum glucagon concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of hepatic glucose production and gluconeogenesis.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum fetuin-A concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of insulin sensitivity and hepatic metabolic response.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum fibroblast growth factor 21 (FGF21) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of metabolic adaptation and energy homeostasis
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum interleukin-6 (IL-6) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Exercise-induced myokine involved in muscle-liver signaling.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in serum myoglobin concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of muscle stress and exercise-induced muscle response.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in STAT3 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of IL-6 signaling pathway activation
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in SOCS3 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of negative feedback regulation of inflammatory signaling.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Changes from baseline in PCK1 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of gluconeogenesis regulation.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in SLC2A4 (GLUT4) gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of skeletal muscle glucose transport
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in plasma lipopolysaccharide (LPS) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of exercise-induced endotoxemia.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in serum lipopolysaccharide-binding protein (LBP) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of endotoxin transport and immune activation.
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum soluble CD14 (sCD14) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
Marker of monocyte activation and endotoxin recognition
|
At rest (before the exercise test), immediately after the end of the test, and after 1 hour of recovery.
|
|
Change from baseline in serum soluble toll-like receptor 4 (sTLR4) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of innate immune receptor activation.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in serum soluble toll-like receptor 2 (sTLR2) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of innate immune response to bacterial components.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in TLR4 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of endotoxin-induced inflammatory signaling
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in TLR2 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of innate immune activation.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in TLR4-positive monocyte expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of monocyte receptor sensitivity to endotoxins.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in TLR2-positive monocyte expression
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of innate immune receptor activation on monocytes.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in serum 8-hydroxy-2'-deoxyguanosine (8-OHdG) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of oxidative DNA damage.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in serum nucleosome concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of chromatin fragmentation and cellular stress.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in serum high mobility group box 1 (HMGB1) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of cellular stress and inflammatory signaling.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in number of apurinic/apyrimidinic (AP) sites
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of DNA strand damage and base excision repair activity.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in APE1/APEX1 protein concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of DNA repair pathway activation.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in poly(ADP-ribose) (PAR) concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of PARP activation and DNA repair response
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in CDKN1A (p21) gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of cell cycle arrest and DNA damage response.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in GADD45A gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of genomic stress response.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in APEX1 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of DNA base excision repair regulation
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in PARP1 gene expression.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of DNA damage sensing and repair signaling.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes from baseline in blood lactate concentration.
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Marker of exercise intensity and metabolic stress.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in hemoglobin concentration
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Assessment of exercise-induced changes in hemoglobin concentration.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in hematocrit value
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Assessment of exercise-induced changes in hematocrit value.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in red blood cell count
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Assessment of exercise-induced changes in red blood cell count.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in mean corpuscular hemoglobin concentration (MCHC)
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Assessment of exercise-induced changes in the average hemoglobin concentration within erythrocytes.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in mean corpuscular volume (MCV)
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Assessment of exercise-induced changes in the average volume of circulating erythrocytes.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Changes from baseline in mean corpuscular hemoglobin (MCH)
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Assessment of exercise-induced changes in the average hemoglobin content per erythrocyte.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Change from baseline in white blood cell count
Lasso di tempo: At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
Assessment of exercise-induced immune and inflammatory responses based on leukocyte, neutrophil, lymphocyte, and monocyte counts.
|
At rest (before the exercise test), immediately after the end of the test, after 1 hour of recovery.
|
|
Profile of Mood States (POMS) score.
Lasso di tempo: Before exercise.
|
Assessment using the Profile of Mood States (POMS) questionnaire.
Total scores range from 0 to 260, with higher scores indicating greater mood disturbance and psychological distress.
|
Before exercise.
|
|
Sport Competition Anxiety Test (SCAT) score.
Lasso di tempo: Before exercise.
|
Assessment using the Sport Competition Anxiety Test (SCAT).
Total scores range from 10 to 30, with higher scores indicating greater trait competitive anxiety.
|
Before exercise.
|
|
Competitive State Anxiety Inventory-2 (CSAI-2) score.
Lasso di tempo: Before exercise.
|
Assessment using the Competitive State Anxiety Inventory-2 (CSAI-2).
Total scores range from 27 to 108, with higher scores indicating greater pre-competition anxiety symptoms and self-confidence levels.
The questionnaire assesses cognitive anxiety, somatic anxiety, and self-confidence.
|
Before exercise.
|
|
Hooper Index score.
Lasso di tempo: Before exercise.
|
Assessment using the Hooper Index questionnaire, calculated as the sum of ratings for fatigue, stress, delayed-onset muscle soreness, and sleep quality.
Total scores range from 4 to 28, with higher scores indicating poorer recovery status and greater overall training strain.
|
Before exercise.
|
|
Change from baseline in mean interstitial glucose concentration
Lasso di tempo: From pre-exercise baseline assessment through exercise and 1-hour post-exercise recovery.
|
Mean interstitial glucose concentration (mg/dL) recorded using a continuous glucose monitoring system during the exercise session and throughout the 1-hour post-exercise recovery period.
CGM-derived glucose values will be averaged across each assessment period and compared with pre-exercise baseline values.
|
From pre-exercise baseline assessment through exercise and 1-hour post-exercise recovery.
|
|
Change from baseline in mean heart rate
Lasso di tempo: From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
Mean heart rate (beats per minute, bpm) continuously recorded using the ONAS10 wearable sensor during exercise and throughout the 1-hour post-exercise recovery period.
|
From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
|
Change from baseline in estimated lactate concentration
Lasso di tempo: From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
Estimated lactate concentration (mmol/L) continuously derived from sweat biomarker analysis using the ONAS10 wearable microfluidic biosensor during exercise and throughout the 1-hour post-exercise recovery period.
|
From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
|
Change from baseline in dehydration rate
Lasso di tempo: From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
Dehydration rate (%) estimated from sweat biomarker analysis using the ONAS10 wearable microfluidic biosensor during exercise and the 1-hour post-exercise recovery period.
|
From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
|
Change from baseline in sweat sodium concentration
Lasso di tempo: From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
Sweat sodium concentration (mg/L or mmol/L) continuously measured using the ONAS10 wearable microfluidic biosensor during exercise and throughout the 1-hour post-exercise recovery period.
|
From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
|
Change from baseline in estimated sodium loss
Lasso di tempo: From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
Estimated sodium loss (mg) derived from sweat analysis using the ONAS10 wearable microfluidic biosensor during exercise and the 1-hour post-exercise recovery period.
|
From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
|
Change from baseline in sweat rate
Lasso di tempo: From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
Sweat rate (mL/h) continuously estimated using the ONAS10 wearable microfluidic biosensor during exercise and throughout the 1-hour post-exercise recovery period.
|
From pre-exercise baseline through exercise and 1-hour post-exercise recovery.
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Anna Skarpańska-Stejborn, Professor, Poznan University of Physical Education, Gorzów Wielkopolski; Faculty of Sport Sciences in Gorzów Wielkopolski; Department of Biological Sciences,
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- Rowers 2026
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su 2000-m rowing ergometer test
-
Poznan University of Physical EducationNon ancora reclutamentoDisturbi dell'umore | Disfunzione endoteliale | Malnutrizione, caloriePolonia
-
Ufuk UniversitySconosciutoSindrome dolorosa femoro-rotuleaTacchino
-
Poznan University of Physical EducationCompletato
-
Poznan University of Physical EducationCompletato
-
Mayo ClinicQatar National Research FundCompletatoSindrome coronarica acutaStati Uniti
-
University of ZurichNational Center of Cardiology and Internal Medicine, Kyrgyz RepublicCompletatoAlta altitudine | Test di simulazione dell'altitudine dell'ipossiaKirghizistan
-
Haute Ecole Ilya PrigogineNon ancora reclutamentoDisturbi del neurosviluppo
-
Afyonkarahisar Health Sciences UniversityReclutamento
-
Bezmialem Vakif UniversityCompletato
-
Cairo UniversitySconosciutoValutazione clinica e radiografica di NIPSA rispetto a M-MIST nel trattamento dei difetti intraosseiParodontite, adultoEgitto